Abstract Background The SARS-CoV-2 coronavirus epidemic is hastening the discovery of
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …

Objective The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on
health all over the world. Cancer patient, whose immunity is often compromised, faces a …

Background Safety and immunogenicity of BNT162b2 mRNA vaccine are unknown in
hematological patients; both were evaluated prospectively in 42 patients with multiple …

PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …

Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

Purpose People living with cancer and haematological malignancies are at an increased
risk of hospitalisation and death following infection with acute respiratory syndrome …

Simple Summary Although COVID-19 vaccine side effects are generally well tolerated,
information on cancer patients is lacking due to their exclusion from original clinical trials …

Objectives Patients with cancer are more vulnerable to COVID-19 morbidity and morbidity
than the general population and have been prioritised in COVID-19 vaccination …

Importance Patients with cancer have an increased risk of severe disease and mortality from
COVID-19, as the disease and antineoplastic therapy cause reduced vaccine …

Simple Summary Cancer patients undergoing active treatment may be more vulnerable to
COVID-19 due to the effects of the malignant disease and the anti-cancer treatment …